Rifampicin (RIF) is a benchmark drug for treatment of tuberculosis, but poor bioavailability, prolonged treatment, and pill burden have been linked to therapeutic failure and the development of multidrug resistant strains. To overcome these limitations, this study investigated a method of rifampicin nanoencapsulation and aerosol delivery using a commercial, hand-held nebulizer modified with a nitrogen stream.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792303 | PMC |
| http://dx.doi.org/10.1039/C5RA25044G | DOI Listing |
Publication Analysis
Top Keywords
self-assembled nanospheres
4
nanospheres encapsulation
4
encapsulation aerosolization
4
aerosolization rifampicin
4
rifampicin rifampicin
4
rifampicin rif
4
rif benchmark
4
benchmark drug
4
drug treatment
4
treatment tuberculosis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!